molecular mechanisms of mcl and their targeting with novel agents
Published 9 years ago • 586 plays • Length 16:20Download video MP4
Download video MP3
Similar videos
-
20:59
targeted inhibition of signal molecules as novel therapy for cll
-
19:58
incorporating novel agents into the therapy of follicular lymphoma
-
22:26
key novel agents for relapsed diffuse large b-cell lymphoma
-
26:17
integrative whole transcriptome sequencing and cyclins in myeloma and mcl therapy
-
13:36
molecular mechanisms of lymphangiogenesis and lymphatic repair - le&rn - acp
-
19:03
the era of precision oncology | dr. jaime l. schneider
-
5:12
aminopterin and hgprt (fl-immuno/52)
-
5:09
cmml morphology-chronic myelomonocytic leukaemia for clinical and lab staff
-
2:48
medial collateral ligament (mcl) injuries
-
23:28
richter’s syndrome: what are the options?
-
20:53
novel small molecules in multiple myeloma: update on key results from emerging clinical studies
-
0:13
knee & medial collateral ligament animation, ©primal pictures ltd
-
24:44
novel therapeutic strategies in b cell lymphomas
-
14:26
novel small molecule inhibitors in multiple myeloma
-
2:00
two minutes of anatomy: medial collateral ligament (mcl)
-
18:21
do we really need to transplant young patients with mantle cell lymphoma?
-
14:07
novel agents in the pipeline for cll & lymphoma
-
3:21
medial collateral ligament (mcl) injuries
-
14:03
clinical considerations for therapy selection in relapsed/refractory mcl
-
0:16
mcl tear explained #shorts
-
0:11
mcl tear rehab: terminal knee extension
-
30:05
who should get what for upfront therapy for mantle cell lymphoma?